Literature DB >> 24358939

Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.

Xiaohua Zhang1, Sergio E Wong, Felice C Lightstone.   

Abstract

In this work we announce and evaluate a high throughput virtual screening pipeline for in-silico screening of virtual compound databases using high performance computing (HPC). Notable features of this pipeline are an automated receptor preparation scheme with unsupervised binding site identification. The pipeline includes receptor/target preparation, ligand preparation, VinaLC docking calculation, and molecular mechanics/generalized Born surface area (MM/GBSA) rescoring using the GB model by Onufriev and co-workers [J. Chem. Theory Comput. 2007, 3, 156-169]. Furthermore, we leverage HPC resources to perform an unprecedented, comprehensive evaluation of MM/GBSA rescoring when applied to the DUD-E data set (Directory of Useful Decoys: Enhanced), in which we selected 38 protein targets and a total of ∼0.7 million actives and decoys. The computer wall time for virtual screening has been reduced drastically on HPC machines, which increases the feasibility of extremely large ligand database screening with more accurate methods. HPC resources allowed us to rescore 20 poses per compound and evaluate the optimal number of poses to rescore. We find that keeping 5-10 poses is a good compromise between accuracy and computational expense. Overall the results demonstrate that MM/GBSA rescoring has higher average receiver operating characteristic (ROC) area under curve (AUC) values and consistently better early recovery of actives than Vina docking alone. Specifically, the enrichment performance is target-dependent. MM/GBSA rescoring significantly out performs Vina docking for the folate enzymes, kinases, and several other enzymes. The more accurate energy function and solvation terms of the MM/GBSA method allow MM/GBSA to achieve better enrichment, but the rescoring is still limited by the docking method to generate the poses with the correct binding modes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24358939     DOI: 10.1021/ci4005145

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  22 in total

1.  Ultrafast protein structure-based virtual screening with Panther.

Authors:  Sanna P Niinivehmas; Kari Salokas; Sakari Lätti; Hannu Raunio; Olli T Pentikäinen
Journal:  J Comput Aided Mol Des       Date:  2015-09-25       Impact factor: 3.686

2.  Negative Image-Based Screening: Rigid Docking Using Cavity Information.

Authors:  Pekka A Postila; Sami T Kurkinen; Olli T Pentikäinen
Journal:  Methods Mol Biol       Date:  2021

3.  Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2-PCCA: Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies.

Authors:  Chunyang Jin; Ann M Decker; Danni L Harris; Bruce E Blough
Journal:  ACS Chem Neurosci       Date:  2016-08-16       Impact factor: 4.418

4.  Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies.

Authors:  Jeffrey M Witkin; Ryan A Shenvi; Xia Li; Scott D Gleason; Julie Weiss; Denise Morrow; John T Catow; Mark Wakulchik; Masaki Ohtawa; Hai-Hua Lu; Michael D Martinez; Jeffrey M Schkeryantz; Timothy S Carpenter; Felice C Lightstone; Rok Cerne
Journal:  Biochem Pharmacol       Date:  2018-06-22       Impact factor: 5.858

5.  Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening.

Authors:  Spencer S Ericksen; Haozhen Wu; Huikun Zhang; Lauren A Michael; Michael A Newton; F Michael Hoffmann; Scott A Wildman
Journal:  J Chem Inf Model       Date:  2017-07-12       Impact factor: 4.956

6.  Performance of a docking/molecular dynamics protocol for virtual screening of nutlin-class inhibitors of Mdmx.

Authors:  Nagakumar Bharatham; Kristin E Finch; Jaeki Min; Anand Mayasundari; Michael A Dyer; R Kiplin Guy; Donald Bashford
Journal:  J Mol Graph Model       Date:  2017-02-24       Impact factor: 2.518

7.  Benchmarking methods and data sets for ligand enrichment assessment in virtual screening.

Authors:  Jie Xia; Ermias Lemma Tilahun; Terry-Elinor Reid; Liangren Zhang; Xiang Simon Wang
Journal:  Methods       Date:  2014-12-03       Impact factor: 3.608

8.  Exploring safe and potent bioactives for the treatment of non-small cell lung cancer.

Authors:  Muthu Kumar Thirunavukkarasu; Woong-Hee Shin; Ramanathan Karuppasamy
Journal:  3 Biotech       Date:  2021-04-26       Impact factor: 2.406

9.  Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.

Authors:  Thuy Nguyen; Thomas F Gamage; Ann M Decker; David B Finlay; Tiffany L Langston; Daniel Barrus; Michelle Glass; Danni L Harris; Yanan Zhang
Journal:  Bioorg Med Chem       Date:  2021-05-12       Impact factor: 3.461

10.  Adverse drug reaction prediction using scores produced by large-scale drug-protein target docking on high-performance computing machines.

Authors:  Montiago X LaBute; Xiaohua Zhang; Jason Lenderman; Brian J Bennion; Sergio E Wong; Felice C Lightstone
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.